The business compounds; the share, so far, does not.
At $19.31 the price requires reported owner earnings to compound +14.7%/yr for a decade; the ex-Predictions core requires +6.9%/yr. The $9.14/share gap between those two paths is what the market pays for Predictions surviving.
Price $19.31 (+2.17% day), Thu Oct 15, 2026 close — re-pulled and corroborated Fri Oct 16, 2026. 52-wk $18.505–$36.98 (high Jan 6, 2026). Shares 496.454M Class A (period-end cover count, Q2 2026 10-Q) → market cap $9,586.5M. Enterprise value (EV) on the governing as-filed bridge: $10,460.1M (debt $1,857.5M − cash $983.9M); on the pro-forma bridge including the Aug 2026 Term B due 2033: $11,160.1M. Both bridges enumerated in Balance Sheet; the reverse DCF prints bars for both. Class B (393,013,951 sh, 10 votes, all held by CEO Jason Robins) has no economic rights and is excluded from EV.
Verdict
Top unverifiable item: Predictions’ revenue, take rate and market-making profit are undisclosed — bundled inside the “Sports” segment. The profit leg of the binary dominating this price cannot be verified from filings.
Quality: A proven volume-and-hold compounder — revenue compounded +47.0%/yr FY21→FY25, Sports Consumer Volume +14.5% in Q2 2026 — whose per-share conversion has failed so far: TTM owner earnings (OE = free cash flow minus stock-based compensation, SBC) are $327.4M after $323.5M of SBC, and the share count rose through $773.8M of buybacks.
Moat: Regulated scale in online sports betting (OSB) and iGaming — licenses, brand, product velocity — intact in the licensed core; its margin is taxed away at the edges, and the growth vector (Predictions) has a moat made of law, not product: courts decide whether it exists.
Price: At $19.31 the price requires reported OE to compound +14.7%/yr for a decade (competitive advantage period, CAP, ~6.6 years even at +20%/yr). The ex-Predictions core requires +6.9%/yr (CAP ~2.2 years at +20%). The $9.14/share gap between those two paths is what the market pays for Predictions surviving. Core-only scenario value: $11.10–$16.64/share at 0–5% core growth, vs $19.31 paid.
Downside flags (surface here by rule): two unaddressed flags from the Pabrai Downside Checklist — leverage on the pro-forma bridge (pro-forma net debt $1,573.6M = 3.15× TTM adjusted EBITDA if the Term B proceeds are not offset) and the regulatory binary (core-only downside −13.8% to −42.5% vs the price).
Management: C+ (re-verified Oct 16, 2026: Form 4 sweep to today, no filing since Oct 2, no insider buys). Guidance C+ · execution B+ · candor B− · capital allocation C+ · alignment C−.
Next tests: Nov 5, 2026 — Q3 print (H2 must deliver $418–618M of adjusted EBITDA vs the maintained guide); Nov 9, 2026 — Kalshi’s Supreme Court response due in No. 26-299.
Key debates
| Debate | What the price assumes | What the record shows | Resolving event + date | What would change the read |
|---|---|---|---|---|
| Can the core clear its own bar? | Core OE compounds at least +6.9%/yr for a decade | Revenue +47.0%/yr FY21→FY25 and iGaming +7.5% in Q2 2026 — but Q2 revenue fell −4.6%, and the guide needs a record second half | Q3 print Nov 5, 2026; FY26 verdict Feb 2027 | Two straight quarters of core revenue growth ≥ +6% at hold ≥ 7% clears it; a Q3 adjusted EBITDA print under $150M breaks the second-half math |
| Is the maintained FY26 guide real? | Adjusted EBITDA lands inside $700–900M | H1 delivered $282.5M, so $418–618M must come in H2; the guide was set Feb 13, 2026 after Robins sent the draft back twice to be lowered — and the year-ahead EBITDA guide has still missed three straight years | Nov 5, 2026 (pace); Feb 2027 (verdict) | Q3 ≥ $209M keeps the guide credible; under $150M, even the $700M floor needs a record Q4 |
| Does the state tax ratchet keep compressing the moat’s margin? | Pass-through pricing and mix hold margins | Illinois’ per-wager fee live since Sep 1, 2025 (wagers −15% YoY that month, handle +9%, ticket +28%); Chicago stacks to 52.25%+; MD, NJ, LA hiked in 2025; Ohio’s doubling was rejected | 2027 state sessions; Illinois HB 5143 (repeal) pending | Another top-five state adopting a per-wager fee extends the ratchet; Illinois repeal would be a first reversal |
| Does Predictions cannibalize the licensed book? | Management’s “~1% overlap” assertion | The assertion is unverifiable — no overlap data is disclosed. FanDuel reports cannibalization of its own book at “low single-digit,” later “very low-single-digit” (Tier 2) | No DKNG disclosure scheduled; competitor prints quarterly | Any DKNG overlap or Predictions-revenue disclosure moves this from assertion to evidence |
| [Price] Does Predictions survive as a lawful nationwide business? | $9.14/share of the price — the gap between the reported-OE path ($10.21/share at core growth) and the ex-Predictions path ($19.35) | Preemption lost 3–0 in both the Sixth (Sep 25, 2026) and Ninth Circuits (Aug 28 / Sep 16, 2026); won preliminarily in the Third (Apr 6, 2026); 39 state AGs + DC urged Supreme Court review against the platforms. Desk band: 25–40% ultimate nationwide win by end-2028 (basis in Legal) | Kalshi response due Nov 9, 2026; cert decision expected by ~Jun 2027; CFTC final rules 2027 | A cert grant plus any preemption win raises the band; a denial leaves state-by-state trench warfare and the core-only grid governs |
| [Price] Will the share count ever fall? | The credited bars assume net shrink management has not delivered | Weighted count rose 482.0M → 495.6M FY24→FY25 through $773.8M of cumulative buybacks; 2026 net shrink ≈ 0%. Remaining authorization $1,226.2M = 12.8% of the count at $19.31 | Year-end count, Feb 2027 | Count under 490M earns the buyback credit; 496.5M or higher retires it for this cycle |
Catalyst calendar
| Date | Event | Debate resolved | Threshold |
|---|---|---|---|
| Nov 5, 2026 | Q3 2026 print + 10-Q | H2 guide math; count direction; post-refi balances | Adjusted EBITDA ≥ $209M pass / < $150M fail; count ≤ 495.0M / ≥ 496.5M |
| Nov 9, 2026 | Kalshi response due, Supreme Court No. 26-299 | The binary’s next procedural step | Filed (binary observable); review not yet granted |
| Feb 2027 | Q4 / FY26 print | FY26 guide verdict; buyback credit earned or retired | FY26 adjusted EBITDA ≥ $700M; year-end count < 490M |
| By ~Jun 2027 | Supreme Court cert decision, No. 26-299 | Whether the binary gets a federal answer this term | Granted / denied (binary observable) |
Drivers
The kill attempt
Bull case
Reverse DCF
Method (house stack): solve the single growth rate that makes a 10-year owner-earnings path, grown at 2% thereafter, worth today’s EV at a 10% required return; terminal value fades to cost-of-capital economics with no exit multiple. OE = FCF − SBC throughout. Full model, inputs and both bridges: reverse_dcf_v3.py / reverse-dcf-v3-2026-10-16.json in the dossier (governing bridge verified against the filed v2 model).
The bridge, both ways (full enumeration in Balance Sheet & Capital Returns). Governing — as filed Jun 30, 2026: debt $1,857.5M, cash $983.9M, net debt $873.6M = 1.75× TTM adjusted EBITDA ($499.2M), EV $10,460.1M. Alternative — pro-forma: the Aug 25, 2026 credit amendment added a $700M Term B due 2033 (8-K acc. 0001104659-26-100812; priced at 99.5, ≈ $696.5M of proceeds) whose proceeds the filing says DKNG “intends to utilize” for opportunistic repurchases of a portion of the 2028 converts plus general corporate purposes. If spent without offsetting the converts — none reported executed as of Oct 16, 2026 — debt is $2,557.5M, net debt $1,573.6M = 3.15× TTM adjusted EBITDA, EV $11,160.1M. The as-filed bridge governs (it is the filed balance sheet); the pro-forma bars print beside it so the assumption is never buried.
| Lens (TTM base) | Flat bar — governing | Flat bar — pro-forma | CAP @ +20% (gov.) | TV % of EV |
|---|---|---|---|---|
| Naive FCF ($650.9M) | +5.2%/yr | +6.1%/yr | — | 50.9% |
| Reported OE ($327.4M) — governing bar | +14.7%/yr | +15.5%/yr | ~6.6 yrs | 60.4% |
| OE ex-Predictions ($577.4M) — core decomposition | +6.9%/yr | +7.8%/yr | ~2.2 yrs | 52.7% |
Required vs delivered (the base-rate line that travels with the bar): the +14.7% reported bar is 2.4× the most recent delivered reported OE growth of +6.2% ($308.2M FY25 → $327.4M TTM), and OE was negative through FY23 — the delivered OE record is two positive years, FY24 (+$26.2M) and FY25 (+$308.2M), plus the TTM ($327.4M). The price asks for a decade at a rate the company has never sustained for even three years. The core lens’s +6.9% bar sits against a richer history — revenue compounding +47.0%/yr FY21→FY25 — the decomposition is where the argument is winnable.
Normalization sensitivity (the ex-Predictions lens is a normalization, so it prints as a range): the lens adds back management’s guided Predictions drag of $200–300M of adjusted EBITDA (both 2026 calls). At the $200M low end the base is $527.4M and the bar is +8.1%/yr; at the $250M midpoint (the filed lens) $577.4M and +6.9%/yr; at $300M, $627.4M and +5.7%/yr. Two caveats ride with it: an adjusted-EBITDA drag is not an OE drag (the add-back is unverified as cash), and segment revenue stays in the base while the spend comes out.
Buyback-credited bars — CONDITIONAL, credit not earned. If net shrink were demonstrated, required total OE growth falls as follows: governing bridge — reported OE +13.5% / +12.4% / +11.2% at 1% / 2% / 3% net shrink; ex-Predictions +5.8% / +4.7% / +3.7%. Pro-forma bridge — reported +14.4% / +13.2% / +12.1%; ex-Predictions +6.7% / +5.6% / +4.5%. The count rose in FY25 and is flat in 2026, so none of this credit is in the verdict.
Turbo trigger: the Predictions path. Grow both bases at the core bar (+6.9%/yr) and the ex-Predictions path is worth $19.35/share while the reported path is worth $10.21 — the spend drag is $9.14/share, which is what the market price embeds for Predictions surviving and converting. The margin-path inversion says the same thing in revenue terms: required revenue growth is +5.3%/yr at a 12% mature OE margin, +2.8% at 15%, +0.8% at 18%, −0.4% at 20% (current TTM OE margin 5.3%). Hurdle sensitivity on the governing reported bar: +10.2% at an 8% hurdle, +12.5% at 9%, +14.7% at 10%, +16.7% at 11%, +18.6% at 12%.
Implied $/share at revenue growth (rows) × mature OE margin (columns), governing bridge; bold = at or above the $19.31 price. The desk’s central cell — the filed inversion, revenue +2.8%/yr at a 15% margin — is the +3% × 15% cell, $19.63.
| Rev CAGR \ Margin | 10% | 12.5% | 15% | 17.5% | 20% |
|---|---|---|---|---|---|
| 0% | $10.18 | $12.63 | $15.08 | $17.53 | $19.98 |
| +3% | $13.29 | $16.46 | $19.63 | $22.80 | $25.97 |
| +6% | $17.21 | $21.31 | $25.40 | $29.50 | $33.59 |
| +9% | $22.16 | $27.43 | $32.69 | $37.96 | $43.22 |
| +12% | $28.38 | $35.12 | $41.86 | $48.60 | $55.34 |
SBC, in full (it stays here, not in the headline): TTM SBC is $323.5M — 5.2% of revenue, down from 52.7% in FY21, but still 49.7% of TTM FCF ($650.9M), which is why the naive-FCF bar (+5.2%) and the OE bar (+14.7%) live in different worlds. Management guides SBC at 6% of revenue against ~$750M of guided FCF (stated on both the May 9, 2025 and Aug 7, 2025 calls); $676.0M of unrecognized SBC cost sits on the balance sheet over a 2.8-year average life. Every bar on this page is struck after charging SBC in full.
Terminal sanity: terminal value is 12.75× year-10 OE on every path by construction; implied terminal EV/EBIT is not meaningful on the reported lens (TTM GAAP EBIT is −$182.4M) and is stated as n/m rather than forced.
What’s growing
| Metric | FY21 | FY22 | FY23 | FY24 | FY25 | TTM (Q2’26) |
|---|---|---|---|---|---|---|
| Revenue | 1,296.0 | 2,240.5 (+72.9%) | 3,665.4 (+63.6%) | 4,767.7 (+30.1%) | 6,054.5 (+27.0%) | 6,222.5 |
| Adj. EBITDA | −675.4 | −721.7 | −151.0 | +181.3 | +620.0 | +499.2 |
| FCF (OCF − capex) | −435.4 | −657.9 | −22.7 | +407.6 | +647.5 | +650.9 |
| SBC | 683.3 | 578.8 | 398.5 | 381.4 | 339.3 | 323.5 |
| Owner earnings (FCF − SBC) | −1,118.7 | −1,236.7 | −421.2 | +26.2 | +308.2 | +327.4 |
| OE margin | n/m | n/m | −11.5% | +0.5% | +5.1% | +5.3% |
| GAAP net income | −1,257.8 | −1,361.9 | −802.1 | −507.3 | +3.7 | +17.8 |
| Shares (period-end Class A, M) | — | — | — | 482.0* | 495.6* | 496.454 |
$ millions except shares. *FY24/FY25 shares are weighted basic (10-K); the TTM figure is the period-end cover count (Q2 10-Q) — different measures, labeled as such. Same-window delivery: revenue +47.0%/yr FY21→FY25; OE swung from −$1,118.7M (FY21) to +$308.2M (FY25), +$327.4M TTM (a sign change — no CAGR printable). The compounding is real; the per-share conversion is the open question.
| Q2 2026 | Value | Note |
|---|---|---|
| Revenue | $1,443.2M (−4.6%) | Sports $891.9M (−10.6%); iGaming $461.9M (+7.5%); Other $89.4M (incl. Lottery/Jackpocket) |
| Sports Consumer Volume | $13,140M (+14.5%) | Demand grew; monetization didn’t |
| Net revenue margin | 6.8% (vs 8.7%) | June customer-friendly outcomes ≈ −$80M revenue (call) |
| MUPs / ARPMUP | 3.6M (+9.1%) / $132 (−12.6%) | More customers, less revenue each |
| Adj. EBITDA | $114.6M (vs $300.6M) | H1 total $282.5M → H2 must deliver $418–618M |
| Buybacks in quarter | $55.6M | Apr 358,133 sh @ $22.12; May 1,112,451 @ $25.18; Jun 783,882 @ $25.02 |
| Count direction | ≈ flat | Net shrink 2026 ≈ 0% after SBC + issuance |
| Predictions | No revenue breakout | Bundled in “Sports”; Robins cited “$11B annualized volume” (his figure, Aug 7, 2026 remarks — Tier 2) |
| Auditor | BDO → Deloitte (FY27) | 8-K Sep 25, 2026; no disagreements |
| Legal (10-Q) | Two prediction-market class actions | D. Mass. Aug 3, 2026; C.D. Cal. Aug 13, 2026 — allegations only |
Management
Grade re-verified Oct 16, 2026 — Form 4 sweep extended to today; latest filing Oct 2, 2026; no insider buys.
Sales & product engine — answered. Volume +14.5% and MUPs +9.1% in a quarter where revenue fell: the machine acquires and retains.
Innovation productivity — answered. Parlay mix drove structural hold 5.6% → 7.1% in two years; Predictions went from announcement to live (Dec 2025) with a vertically integrated stack (DKeX exchange, Jun 2026; NFA FCM approval, Jul 2026).
Cost & margin discipline — thin. Promo efficiency is claimed every call; the June outcomes hit (−$80M) and the undisclosed Illinois fee impact keep it thin.
Long-range outlook vs quarterly pressure — answered, adversely. Two investor days: Nov 14, 2023’s ~$1.4B 2026 EBITDA target will miss by ~half (the revenue leg hit a year early); Mar 2, 2026’s $55–80B 2030 industry frame and ≥30% long-term margin are not yet testable against a TTM consolidated margin of 8.0%.
Access — thin on the decisive item. Calls are forthcoming on the core; on Predictions — the item that prices the stock — revenue, take and overlap are all withheld.
Bench depth — thin: no evidence of a second operator was pulled for this edition; flagged, not filled.
Integrity — the capstone gate, and it caps the grade. A CEO who sends his own guide back twice to be lowered (Feb 13, 2026) earns candor credit; a founder group that has sold $363.0M, bought $0, and keeps settling prepaid forwards does not earn alignment credit. Both are true; the grade holds both.
| Sub-grade | Grade | Basis (behavior, not statements) |
|---|---|---|
| Guidance credibility | C+ | FY26 guide built conservatively (sent back twice, Feb 13, 2026), maintained Aug 7, 2026 — but the year-ahead adjusted EBITDA guide has missed three straight years |
| Execution | B+ | Volume, hold, iGaming and the Predictions launch all delivered; Q2 2026’s miss was outcomes, not operations |
| Candor | B− | Self-indictment on the record (“missing numbers again is just not acceptable”); Jackpocket/GNOG EBITDA walk-back disclosed; Predictions metrics withheld |
| Capital allocation | C+ | Refinancing termed out maturities (converts 2028, Term B 2032/2033, revolver 2031); buybacks bought a rising count at a $34.24 average into a $19.31 price |
| Alignment | C− | Zero open-market buys, ever, in the sweep window; founders sold ≈ $363.0M; 6,113,810 Kalish shares pledged or under prepaid forwards |
| Guide | Initial | Final / delivered | Verdict |
|---|---|---|---|
| FY23 (set Nov 2022) | −250 to −150 (mid −200) | Raised in-year to a −95 to −115 final guide; delivered −151.0 | Miss — below the final guide (and a hair below the initial range’s top) |
| FY24 (set Feb 16, 2024; raised Nov 2024) | ~+150 mid (implied) | Initial guide missed; delivered +181.3 | Miss vs initial |
| FY25 (set Feb 14, 2025) | 900–1,000 | Cut May (800–900), maintained Aug, cut Nov (450–550); delivered 620.0 | Beat the final guide — above $450–550M; still ~a third below the initial guide |
| FY26 (set Feb 13, 2026) | 700–900 | Maintained Aug 7, 2026; H1 delivered 282.5 → H2 needs 418–618 | Open; verdict Feb 2027 |
Form 4 record (Tier 1; sweep extended to Oct 16, 2026 — EDGAR re-pull today confirms the latest filing is the Oct 2, 2026 Form 4): no open-market buys and no open-market sales by Robins, Liberman, Kalish or Ellingson since Sep 1, 2026 — including through the $18.505 low on Oct 14. Non-market items only: Sep 1 RSU vests (tax withholding at $23.44); Robins’ Sep 3 gift of 12,000 shares and Sep 11 GRAT transfer (696,850 shares + 800,000 options, no purchase/sale); Kalish’s Aug 12 exercise of 383,455 options at $4.70 and Sep 2 delivery of 864,880 shares settling his Sep 2023 prepaid forward (a real disposition of shares he was paid $18,718,918 for in 2023 — settlement, not a new sale); director Moore’s Aug 19 sale of 10,759 shares at $24.05 under her May 2026 10b5-1. Kalish’s total encumbrance: 4,201,574 pledged shares (Mar 2026 proxy) plus 1,912,236 shares under a new May 15, 2026 prepaid forward (delivery May 18, 2029) = 6,113,810 shares. Robins pledges a further 3,153,552 and controls 88.3% of the vote through Class B.
Moat & durability
Balance sheet & capital returns
As filed, Jun 30, 2026 (Q2 10-Q): funded debt $1,857.5M = 0% convertible notes due 2028, $1,265.0M principal (conversion price ≈ $94.85; capped calls to $135.50) + Term B due 2032, $592.5M (SOFR + 1.75%, weighted average cost 5.39%). Cash and equivalents $983.9M; net debt $873.6M = 1.75× TTM adjusted EBITDA ($499.2M). Book equity $569.4M. Restricted cash $8.6M; user-reserved cash $395.0M against user liabilities $840.3M (segregated player funds, not netted). No dividend, ever.
Pro-forma (the alternative bridge, printed because the assumption matters): the Aug 25, 2026 amendment (8-K, acc. 0001104659-26-100812) added a $700M Term B due 2033 at SOFR + 2.00%, priced at 99.5 (≈ $696.5M of proceeds), and replaced the $500M revolver due 2029 with a $750M revolver due 2031 (undrawn at last report). The filing earmarks proceeds for opportunistic repurchases of a portion of the 2028 converts and general corporate purposes. Until a repurchase is reported, the honest pro-forma is debt $2,557.5M, cash unchanged, net debt $1,573.6M = 3.15× TTM adjusted EBITDA, EV $11,160.1M — the bridge the Downside Checklist grades. The Nov 5 10-Q is the first document that can retire this assumption either way.
Capital returns: cumulative buybacks $773.8M at a ~$34.24 average through Jun 30, 2026; $1,226.2M of authorization remains (12.8% of the Class A count at $19.31). The program’s record in one line: it has spent three-quarters of a billion dollars and the share count is higher than when it started, because SBC and issuance refill it. Auditor rotation: BDO → Deloitte for FY2027 (8-K Sep 25, 2026, no disagreements).
Legal & the Predictions binary
The map is split, and the split is the risk. Third Circuit (Apr 6, 2026, preliminary): sports event contracts are likely “swaps,” federal preemption likely — platforms win. Ninth Circuit (Aug 28, 2026, Nevada; Sep 16, 2026, tribal IGRA claims): against preemption. Sixth Circuit (Sep 25, 2026, OH/TN): against preemption — and the panel also held the contracts are not swaps. The swaps prong thus also lost in the only full merits panel to reach it. New Jersey’s Supreme Court petition (Flaherty v. KalshiEX, No. 26-299, filed Sep 2, 2026) drew an amicus wave against the platforms (Oct 6–9, 2026 filings): 39 state AGs + DC, 145 tribal entities, the NFL, the American Gaming Association; Kalshi’s response is due Nov 9, 2026; review not granted as of Oct 16, 2026 (docket re-checked Oct 16: nothing since Oct 9). The CFTC moved Oct 9, 2026: a proposed rule (RIN 3038-AF82) defining “swap” to include sports event contracts, and an interim final rule (RIN 3038-AF81) excluding house-banked casino-style products. That strengthens the swap prong; it does not decide preemption, the prong the Sixth and Ninth Circuits ruled on. DKNG’s own Q2 10-Q Legal Proceedings carries two prediction-market class actions — D. Mass. (1:26-cv-13525, filed Aug 3, 2026) and C.D. Cal. (8:26-cv-02199, filed Aug 13, 2026) — allegations only, no rulings.
What the binary is worth — core-only scenario (labeled scenario math, built from this page’s ex-Predictions lens): value the core alone — base OE $577.4M, the ~$250M/yr Predictions spend stopped, governing net debt $873.6M — and Predictions contributes zero:
| Core OE growth for a decade | Implied $/share | vs $19.31 |
|---|---|---|
| 0% | $11.10 | −42.5% |
| +3% | $14.17 | −26.6% |
| +5% | $16.64 | −13.8% |
| +6.9% (the core bar itself) | $19.35 | +0.2% |
| +10% | $24.70 | +27.9% |
Read: at the core’s own required bar, the core alone carries the price — the $19.31 buyer is paying ≈ nothing for Predictions if the core compounds at +6.9% and the spend stops cleanly. Every point of core growth below that bar is paid for by the binary. Excluded from the grid: wind-down costs, the value of Predictions’ 600K+ acquired customers if the product dies, and license jeopardy in licensed states — the first two cut opposite ways, the third only one way.
Charts · Qualtrim
Pabrai Downside Checklist
| Category | Item | Verdict |
|---|---|---|
| Valuation | The governing bar (+14.7%/yr reported OE) is 2.4× the most recent delivered rate (+6.2%, FY25 → TTM); the historical mistake this descends from is paying a compounder price for a conversion that hasn’t happened | FLAG — sized: core-only downside −13.8% to −42.5% prints on the page; the flag stands until delivered OE growth closes on the bar |
| Leverage | As-filed net debt 1.75× TTM adjusted EBITDA passes; the pro-forma bridge is 3.15× on an unverified proceeds-offset assumption | FLAG — surfaces in the verdict box. Retires when the Nov 5 10-Q shows converts actually repurchased |
| Management & ownership | Founders sold ≈ $363.0M, bought $0; 6,113,810 Kalish shares pledged or under forwards; the CEO controls 88.3% of the vote with no economic Class B stake | FLAG. The C+ grade and the C− alignment sub-grade are this flag, priced into the read |
| Moat | Tax ratchet compressing the margin the moat earns; the growth vector’s legality decided by courts | FLAG — the binary surfaces in the verdict box. The licensed-core moat itself passes |
| Bias | The desk’s own: a 52-week-low price invites a “cheap” reflex; the TAM narrative invites story-over-series; the $34.24 average buyback price invites anchoring | FLAG — mitigated, not cleared: bars are computed from filings, the delivered series prints beside each bar, and the kill attempt leads the body |
No flag is waived. Two (leverage, binary) are unaddressed by any evidence in hand and therefore sit in the verdict box, per the standard.
Checkpoints
Corrections
Gaps & completeness
Stated plainly: (1) Predictions’ revenue, take rate, market-making P&L and customer overlap are undisclosed — the decisive segment cannot be verified, only bounded (core-only grid, Legal). (2) Post-refi balances (converts repurchased? revolver drawn?) do not exist until the Nov 5 10-Q. (3) No company-stated dollar impact of the Illinois per-wager fee exists; analyst figures (~$79–80M, inconsistently attributed) are refused as fact. (4) Jackpocket/GNOG standalone returns are unverifiable — the 10-K states segment disclosure is impracticable. (5) Michigan’s per-wager proposal final disposition and the Chicago tax suit’s outcome post-Mar 2026 are unconfirmed. (6) Management’s ~1% overlap and 80–90% professional-volume figures are assertions, flagged wherever used. (7) Q3 2026 results do not exist until Nov 5. Completeness: every material figure in the v3 dossier (report-v3v4-2026-10-16.md) appears in the section named in the dossier’s completeness note (completeness-note-v3-2026-10-16.md), which also carries the computed-but-unpublished register and the SWOT-migration attestation — all 22 internal/external factors from the prior edition carried to their mapped homes (verdict box, drivers, Fisher skeletons, Key Debates, Downside Checklist); none cut. Twelve quarters of earnings calls (Q3 2023–Q2 2026) were read in full and are incorporated — quotes dated throughout; there is no transcript exception for this name. The management grade is re-verified, not inherited: Form 4 sweep extended to Oct 16, 2026, latest proxy (DEF 14A, Mar 26, 2026) re-read, buyback/count re-derived, calls since the grade date checked.
Sources
SEC EDGAR CIK 0001883685: FY2025 10-K (Feb 13, 2026, acc. 0001883685-26-000013); Q2 2026 10-Q (Aug 7, 2026, acc. 0001883685-26-000029) incl. Item 5 (Kalish May 2026 forward); Q2 earnings release 8-K Ex 99.1 (Aug 6, 2026); credit-amendment 8-K (Aug 25, 2026, acc. 0001104659-26-100812); auditor-change 8-K (Sep 25, 2026, acc. 0001883685-26-000034); DEF 14A (Mar 26, 2026, acc. 0001104659-26-035176); Form 4 XMLs (aggregation Jan 2024–Oct 13, 2026 + refresh sweep Sep 1–Oct 16, 2026; submissions index re-pulled Oct 16 — latest filing Oct 2, 2026); EDGAR company facts (FY21–FY23 series). Transcripts: 12 quarters, Motley Fool ×5 / MarketBeat ×7 full text, via the desk transcript library. Legal: Supreme Court docket No. 26-299 (re-checked Oct 16, 2026); circuit rulings and CFTC Oct 9, 2026 releases (RIN 3038-AF81 / AF82). Price: $19.31 = Thu Oct 15, 2026 close (Yahoo chart API pull and Finnhub previous-close corroboration, Oct 16, 2026; intraday Oct 16 traded lower — the page is priced on the last completed close). Tracker figures (PM Pulse/Aldrin via SportsBookReview; DeFi Rate) are Tier 3 and labeled wherever used. No analyst estimates in any model input.